Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Charlie Hospital Semarang Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M, volume 24 jam 592,2 rb), sedangkan Charlie Hospital Semarang Tbk. diperdagangkan di Rp270 (kapitalisasi pasar 742 M, volume 24 jam 29,45 jt). Perbedaan utamanya: Charlie Hospital Semarang Tbk. jauh lebih besar — sekitar 4,3× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Charlie Hospital Semarang Tbk. lebih aktif diperdagangkan (29,45 jt vs 592,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | RSCH | |
|---|---|---|
Kapitalisasi Pasar | 172,82 M | 742 M |
Volume | 592,2 rb | 29,45 jt |
Lot | 5,92 rb | 294,49 rb |
Perputaran | 147,05 jt | 8,14 M |
Harga Rata-rata | 248,31 | 276,35 |
Nilai Transaksi | 147,05 jt | 8,14 M |
Harga Ekuilibrium Indikatif | 254 | 270 |
Volume Ekuilibrium Indikatif | 10 | 103 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →